ATE181104T1 - Isoliertes pctd plasmid aus chlamydia trachomatis von serotyp d, dessen genen und davon kodierten proteine, rekombinante plasmide für die expression von deren genen als fusionsproteine in einem keterologen system, und ihre verwendung als impfstoff- und/oder diagnostiekformulierung - Google Patents

Isoliertes pctd plasmid aus chlamydia trachomatis von serotyp d, dessen genen und davon kodierten proteine, rekombinante plasmide für die expression von deren genen als fusionsproteine in einem keterologen system, und ihre verwendung als impfstoff- und/oder diagnostiekformulierung

Info

Publication number: ATE181104T1
Authority: AT; Austria
Prior art keywords: genes; plasmid; isolated; keterological; pctd
Prior art date: 1991-02-07

Application number

AT91106110T

Other languages

English (en)

Inventor

Giulio Ratti

Maurizio Comanducci

Mario F Tecce

Marzia M Giuliani

Original Assignee

Sclavo Spa

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1991-02-07

Filing date

1991-04-17

Publication date

1999-06-15

1991-04-17 Application filed by Sclavo Spa filed Critical Sclavo Spa

1999-06-15 Application granted granted Critical

1999-06-15 Publication of ATE181104T1 publication Critical patent/ATE181104T1/de

Links

108090000623 proteins and genes Proteins 0.000 title abstract 7
102000004169 proteins and genes Human genes 0.000 title abstract 4
239000013612 plasmid Substances 0.000 title abstract 3
241000606153 Chlamydia trachomatis Species 0.000 title abstract 2
238000009472 formulation Methods 0.000 title abstract 2
239000000203 mixture Substances 0.000 title abstract 2
229960005486 vaccine Drugs 0.000 title abstract 2
229940038705 chlamydia trachomatis Drugs 0.000 title 1
102000037865 fusion proteins Human genes 0.000 title 1
108020001507 fusion proteins Proteins 0.000 title 1
208000015181 infectious disease Diseases 0.000 abstract 2
241000894006 Bacteria Species 0.000 abstract 1
241000588724 Escherichia coli Species 0.000 abstract 1
238000002405 diagnostic procedure Methods 0.000 abstract 1
230000004927 fusion Effects 0.000 abstract 1
230000002163 immunogen Effects 0.000 abstract 1
238000000034 method Methods 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/295—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Chlamydiales (O)
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
- C07K16/1203—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria
- C07K16/125—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria from Chlamydiales (O)
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/74—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
- C07K2319/74—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor
- C07K2319/75—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor containing a fusion for activation of a cell surface receptor, e.g. thrombopoeitin, NPY and other peptide hormones

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Genetics & Genomics (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Engineering & Computer Science (AREA)
Biochemistry (AREA)
Biophysics (AREA)
General Health & Medical Sciences (AREA)
Molecular Biology (AREA)
Biotechnology (AREA)
Bioinformatics & Cheminformatics (AREA)
Zoology (AREA)
Wood Science & Technology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Biomedical Technology (AREA)
Medicinal Chemistry (AREA)
General Engineering & Computer Science (AREA)
Plant Pathology (AREA)
Immunology (AREA)
Microbiology (AREA)
Physics & Mathematics (AREA)
Gastroenterology & Hepatology (AREA)
Peptides Or Proteins (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)

AT91106110T 1991-02-07 1991-04-17 Isoliertes pctd plasmid aus chlamydia trachomatis von serotyp d, dessen genen und davon kodierten proteine, rekombinante plasmide für die expression von deren genen als fusionsproteine in einem keterologen system, und ihre verwendung als impfstoff- und/oder diagnostiekformulierung ATE181104T1 (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
ITMI910314A IT1244706B (it)	1991-02-07	1991-02-07	Plasmide pctd isolato da chlamydia trachomatis serotipo d, suoi geni e proteine da essi codificate; plasmidi ricombinanti per l'espressionedi detti geni in sistemi eterologhi come proteine ricombinanti di fusione, preparazione di dette proteine ricombinanti e loro uso nella formulazione di vaccini e/o diagnostici

Publications (1)

Publication Number	Publication Date
ATE181104T1 true ATE181104T1 (de)	1999-06-15

Family

ID=11358472

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT91106110T ATE181104T1 (de)	1991-02-07	1991-04-17	Isoliertes pctd plasmid aus chlamydia trachomatis von serotyp d, dessen genen und davon kodierten proteine, rekombinante plasmide für die expression von deren genen als fusionsproteine in einem keterologen system, und ihre verwendung als impfstoff- und/oder diagnostiekformulierung

Country Status (8)

Country	Link
US (2)	US6110705A (de)
EP (1)	EP0499681B1 (de)
AT (1)	ATE181104T1 (de)
DE (1)	DE69131319T2 (de)
DK (1)	DK0499681T3 (de)
ES (1)	ES2136062T3 (de)
GR (1)	GR3030447T3 (de)
IT (1)	IT1244706B (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5629167A (en)	1994-04-19	1997-05-13	Biocine S.P.A.	Detection of antibodies against Chlamydia trachomatis pgp3 antigen in patient sera by enzyme-linked immunosorbent assay
US5814490A (en) *	1996-06-11	1998-09-29	Becton, Dickinson And Company	Amplification and detection of chlamydia trachomatis nucleic acids
IL119938A (en) *	1996-12-30	2005-08-31	Yissum Res Dev Co	Peptides capable of eliciting protective immunity against toxic shock induced by pyrogenic exotoxins or of antagonizing toxin-mediated activation of t cells
GB9828000D0 (en)	1998-12-18	1999-02-10	Chiron Spa	Antigens
US7090973B1 (en) *	1999-04-09	2006-08-15	Oscient Pharmaceuticals Corporation	Nucleic acid sequences relating to Bacteroides fragilis for diagnostics and therapeutics
GB0016814D0 (en)	2000-07-07	2000-08-30	Lee Helen	Improved dipstick assays (3)
ATE406912T1 (de)	2001-12-12	2008-09-15	Novartis Vaccines & Diagnostic	Immunisierung gegen chlamydia tracheomatis
WO2008134085A1 (en) *	2007-05-01	2008-11-06	Board Of Regents, University Of Texas System	Chlamydial antigens as reagents for diagnosis and treatment of chlamydial infection and disease
CA2739111A1 (en)	2008-10-09	2010-04-15	Board Of Regents, University Of Texas System	Methods and compositions for chlamydial antigens for diagnosis and treatment of chlamydial infection and disease

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ATE143414T1 (de) *	1985-01-14	1996-10-15	Chiron Corp	Hauptprotein der aussenmembran von chlamydia
GB8709746D0 (en) *	1987-04-24	1987-05-28	Wenman W M	Chlamydia vaccine
IT1224253B (it) *	1988-04-08	1990-09-26	Sclavo Spa	Oligonucleotidi sintetici utili per la determinazione di chlamydia trachomatis in un campione biologico

1991
- 1991-02-07 IT ITMI910314A patent/IT1244706B/it active IP Right Grant
- 1991-04-17 AT AT91106110T patent/ATE181104T1/de not_active IP Right Cessation
- 1991-04-17 ES ES91106110T patent/ES2136062T3/es not_active Expired - Lifetime
- 1991-04-17 EP EP91106110A patent/EP0499681B1/de not_active Expired - Lifetime
- 1991-04-17 DE DE69131319T patent/DE69131319T2/de not_active Expired - Lifetime
- 1991-04-17 DK DK91106110T patent/DK0499681T3/da active
1995
- 1995-05-18 US US08/444,189 patent/US6110705A/en not_active Expired - Lifetime
1997
- 1997-11-13 US US08/969,644 patent/US6096519A/en not_active Expired - Fee Related
1999
- 1999-06-10 GR GR990401491T patent/GR3030447T3/el unknown

Also Published As

Publication number	Publication date
US6096519A (en)	2000-08-01
DE69131319D1 (de)	1999-07-15
DK0499681T3 (da)	1999-11-15
EP0499681A1 (de)	1992-08-26
ITMI910314A0 (it)	1991-02-07
US6110705A (en)	2000-08-29
ITMI910314A1 (it)	1992-08-07
EP0499681B1 (de)	1999-06-09
ES2136062T3 (es)	1999-11-16
IT1244706B (it)	1994-08-08
GR3030447T3 (en)	1999-09-30
DE69131319T2 (de)	1999-12-16

Similar Documents

Publication	Publication Date	Title
ATE123065T1 (de)	1995-06-15	Proteine und deren herstellung.
KR970707281A (ko)	1997-12-01	풀리뉴클레오티드 결핵 백신(A polynucleotide tuberculosis vaccine)
ATE181572T1 (de)	1999-07-15	Ospa proteine von borrelia burgdorferi untergruppen, dafür kodierende gene sowie impfstoffe
SG48353A1 (en)	1998-04-17	Helicobacter pylori proteins useful for vaccines and diagnostics
ATE263836T1 (de)	2004-04-15	Chimere proteine, welche borrelia polypeptide beinhalten, verwendungen dafür
ES555124A0 (es)	1987-03-01	Procedimiento de preparar particulas que contienen secuencias de aminoacidos y que tienen propiedades inmunogenas
DE69427824D1 (de)	2001-08-30	Impfstoffe bestehend aus protein- oder peptid-"cochleaten" und deren verwendung zur immunisierung
DE69735207T2 (de)	2006-11-02	Neuartiges, fibrinogen-bindendes protein, welches von einem koagulase-negativen staphylokokkus abstammt
ATE181104T1 (de)	1999-06-15	Isoliertes pctd plasmid aus chlamydia trachomatis von serotyp d, dessen genen und davon kodierten proteine, rekombinante plasmide für die expression von deren genen als fusionsproteine in einem keterologen system, und ihre verwendung als impfstoff- und/oder diagnostiekformulierung
DK0425082T3 (da)	1995-07-03	Vacciner
DE69223502T2 (de)	1998-07-16	Gen für die glykoprotease aus pasteurella haemolytica
DE69019359D1 (de)	1995-06-14	Menschliche parvovirus-b19-proteine und virusähnliche partikeln, deren herstellung sowie deren verwendung in diagnostischen tests und in impfstoffen.
FI902569A0 (fi)	1990-05-23	Producering av till gonorre anslutande pi-proteiner och vaccin.
DE69330778T2 (de)	2002-07-04	Vogel-mycoplasmaantigen, sein gen, das gen enthaltender rekombinanter vektor, und damit hergestellter impfstoff
US6783764B1 (en)	2004-08-31	Actinobacillus pleuropneumoniae subunit vaccine
GB9727512D0 (en)	1998-02-25	Fuzzy genes and their application in molecular adjuvants
DE3878553T2 (de)	1993-09-02	Klonierung und sequenzierung des gens, das fuer eine neue pilinische untereinheit von bordetella pertussis kodiert.
AU5625796A (en)	1997-01-23	Protective epitopes of adenyl cyclase-haemolysin(AC-Hly), their application to the treatment or to the prevention of bordetella infections
EP1518558B1 (de)	2013-11-20	Impfstoffe gegen Actinobacillus pleuropneumoniae Infektion, die hochreines Toxin enthalten
NO890174L (no)	1989-07-17	Rekombinante interleukin-1alfa-polypeptider.
ATE435915T1 (de)	2009-07-15	Spezifische nukleinsäuren und polypeptide aus krankheitserregenden stämmen von neisseria
IT1202612B (it)	1989-02-09	Plasmidi ricombinanti utili per l'espressione in bacillus di proteine eterologhe
BR0012740A (pt)	2002-05-28	Compostos para tratamento de distúrbios do sistema infeccioso e imune e métodos para seu emprego
KR970700770A (ko)	1997-02-12	Htra-프로모터를 사용하여 독성이 약화된 박테리아내에서 이종 단백질을 발현시키는 방법(expression of heterologous proteins in attenuated bacteria using the htra-promoters)
Hodges et al.	1984	Immunodominant region of EDP 208 pili: Antigen-antibody interaction.

Legal Events

Date	Code	Title	Description
2000-02-15	UEP	Publication of translation of european patent specification
2011-07-15	EELA	Cancelled due to lapse of time